Dr. Ross Bathgate becomes Scientific co-founder of LASEREDD Therapeutics
GPCR News
- Jul 1, 2022
- 1 min
Confo Therapeutics receives €1.7 million VLAIO grant for further research on GPCR modulators for ...
- Jul 1, 2022
- 1 min
Sosei Heptares recently hosted their annual Scientific Advisory Board (SAB)
- Jul 1, 2022
- 1 min
Orion and Peptilogics are pursuing AI-driven drug discovery to explore new functional chemical ...
- Jul 1, 2022
- 1 min
Tectonic Therapeutic Strengthens Leadership Team
- Jul 1, 2022
- 1 min
Addex raises $4.2 million in equity financing
- Jul 1, 2022
- 1 min
Cancer Research UK and Sosei Heptares sign agreement to advance cancer immunotherapy candidate ...
- Jun 1, 2022
- 1 min
Third Rock pushes newest fund over $1B line as it marks 15 years in venture capital
- Jun 1, 2022
- 1 min
Orion Shares New Data on its Latest Best-in-Class Drug Candidate
- Jun 1, 2022
- 1 min
Accelerating GPCR Drug Discovery With Conformation-Stabilizing VHHs
- Jun 1, 2022
- 1 min
Neurocrine Biosciences Presents Data on Treatment of Adolescent Patients with Classic Congenital ...
- Jun 1, 2022
- 1 min
Michel Bouvier appointed Knight of the Ordre national du Québec
- Jun 1, 2022
- 1 min
Crinetics Presents Clinical And Research Results At ENDO 2022
- Jun 1, 2022
- 1 min
GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
- May 1, 2022
- 1 min
Sosei Heptares and Kallyope Enter Collaboration to Identify and Validate Novel Gastrointestinal GPCR
- May 1, 2022
- 1 min
Targeting the M1 muscarinic receptor in neurodegenerative disease
- May 1, 2022
- 1 min
Inversago Pharma appoints Glenn S. Vraniak as Chief Financial Officer
- May 1, 2022
- 1 min
AcroScreen co-founder Margaux Duchamp has been selected as a 30 under 30 Europe Forbes ranking 2022
- May 1, 2022
- 1 min
GPCR Therapeutics Expands Scientific Advisory Board
- May 1, 2022
- 1 min
Domain Therapeutics Raises $42m Series A Financing